A compound with the SMILES CCN1C[C@@]2(COC)C3[C@@H](OC)[C@H]4[C@@H]1[C@@]3(C1C[C@H]3[C@H](OC(C)=O)C1[C@]4(OC(C)=O)C[C@H]3OC)[C@@H](OC)C[C@H]2OC(C)=O has a hERG inhibition at a concentration of 1uM of 1.039\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1C[C@@]2(COC)C3[C@@H](OC)[C@H]4[C@@H]1[C@@]3(C1C[C@H]3[C@H](OC(C)=O)C1[C@]4(OC(C)=O)C[C@H]3OC)[C@@H](OC)C[C@H]2OC(C)=O
CCN1C[C@@]2(COC)C3[C@@H](OC)[C@H]4[C@@H]1[C@@]3(C1C[C@H]3[C@H](OC(C)=O)C1[C@]4(OC(C)=O)C[C@H]3OC)[C@@H](OC)C[C@H]2OC(C)=O
[(1S,4S,5R,6R,8R,9R,10R,13R,14R,16S,18R)-4,8-diacetyloxy-11-ethyl-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-14-yl] acetate